Skip to main content

Pylera Side Effects

Generic name: bismuth subcitrate potassium / metronidazole / tetracycline

Medically reviewed by Drugs.com. Last updated on Sep 3, 2023.

Note: This document contains side effect information about bismuth subcitrate potassium / metronidazole / tetracycline. Some dosage forms listed on this page may not apply to the brand name Pylera.

Applies to bismuth subcitrate potassium / metronidazole / tetracycline: oral capsule.

Warning

Oral route (Capsule)

Potential for CarcinogenicityMetronidazole has been shown to be carcinogenic in mice and rats. It is unknown whether metronidazole is associated with carcinogenicity in humans.

Serious side effects of Pylera

Along with its needed effects, bismuth subcitrate potassium/metronidazole/tetracycline may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.

Check with your doctor immediately if any of the following side effects occur while taking bismuth subcitrate potassium / metronidazole / tetracycline:

More common

Less common

Rare

Incidence not known

Other side effects of Pylera

Some side effects of bismuth subcitrate potassium / metronidazole / tetracycline may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.

Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:

More common

Less common

For Healthcare Professionals

Applies to bismuth subcitrate potassium / metronidazole / tetracycline: oral capsule.

General

The most commonly reported side effects included abnormal feces, nausea, and diarrhea.[Ref]

Gastrointestinal

Very common (10% or more): Abnormal feces (up to 15.6%)

Common (1% to 10%): Nausea, diarrhea, abdominal pain, dyspepsia, constipation, dry mouth

Frequency not reported: Flatulence, glossitis, vomiting, tongue darkening, gastritis, gastroenteritis, duodenal ulcer

Postmarketing reports: Abdominal distention, eructation, flatulence, pseudomembranous colitis/Clostridium difficile colitis

Metronidazole:

Frequency not reported: Nausea, vomiting, diarrhea, abdominal pain, constipation, furry tongue, glossitis, stomatitis, dry mouth, pancreatitis

Tetracycline:

Frequency not reported: Nausea, vomiting, diarrhea, glossitis, black hairy tongue, dysphagia, enterocolitis, anogenital region inflammatory lesions/inflammatory lesions with Candida overgrowth, esophagitis, esophageal ulceration[Ref]

Nervous system

Common (1% to 10%): Headache, dysgeusia, dizziness

Frequency not reported: Somnolence

Postmarketing reports: Peripheral neuropathy

Metronidazole:

Frequency not reported: Metallic taste, convulsive seizures, encephalopathy, aseptic meningitis, peripheral neuropathy, headache, syncope, dizziness, vertigo, incoordination, ataxia, dysarthria

Tetracycline:

Frequency not reported: Intracranial hypertension, pseudotumor cerebri[Ref]

Other

Common (1% to 10%): Asthenia, abnormal laboratory tests

Frequency not reported: Malaise

Postmarketing reports: Fatigue, candidiasis

Metronidazole:

Frequency not reported: Candida overgrowth, fever, weakness

Tetracycline:

Frequency not reported: Tinnitus[Ref]

Genitourinary

Common (1% to 10%): Vaginal infection, urine abnormality

Metronidazole:

Frequency not reported: Vaginal/vulvar dryness, dysuria, polyuria, incontinence, darkened urine, pelvic pressure, dyspareunia, proctitis[Ref]

Hepatic

Common (1% to 10%): ALT increase, AST increase

Tetracycline:

Frequency not reported: Hepatotoxicity, liver failure[Ref]

Dermatologic

Common (1% to 10%): Maculopapular rash

Uncommon (0.1% to 1%): Rash

Frequency not reported: Pruritus

Postmarketing reports: Stevens-Johnson syndrome, toxic epidermal necrolysis, drug rash with eosinophilia and systemic symptoms (DRESS)

Metronidazole:

Frequency not reported: Urticaria, erythematous rash, pruritus

Tetracycline:

Frequency not reported: Maculopapular/erythematous rash, onycholysis, nail discoloration, exfoliative dermatitis, photosensitivity, urticaria, Henoch-Schonlein purpura, systemic lupus erythematosus exacerbation[Ref]

Cardiovascular

Frequency not reported: Chest pain, tachycardia

Postmarketing reports: Chest discomfort

Metronidazole:

Frequency not reported: T-wave flattening, flushing

Tetracycline:

Frequency not reported: Pericarditis[Ref]

Metabolic

Frequency not reported: Increased appetite, increased weight

Metronidazole:

Frequency not reported: Anorexia

Tetracycline:

Frequency not reported: Anorexia[Ref]

Musculoskeletal

Frequency not reported: Back pain, increased blood creatinine phosphokinase, myalgia

Metronidazole:

Frequency not reported: Joint pain

Tetracycline:

Frequency not reported: Myasthenic syndrome[Ref]

Ocular

Frequency not reported: Visual disturbance

Metronidazole:

Frequency not reported: Optic neuropathy[Ref]

Hematologic

Metronidazole:

Frequency not reported: Reversible neutropenia/leukopenia, reversible thrombocytopenia

Tetracycline:

Frequency not reported: Hemolytic anemia, thrombocytopenia, thrombocytopenic purpura, neutropenia, eosinophilia

Renal

Metronidazole:

Frequency not reported: Cystitis

Tetracycline:

Frequency not reported: Increased blood urea nitrogen

Psychiatric

Frequency not reported: Anxiety

Metronidazole:

Frequency not reported: Confusion, irritability, depression, insomnia, decreased libido[Ref]

Hypersensitivity

Tetracycline:

Frequency not reported: Angioedema, anaphylaxis[Ref]

Immunologic

Tetracycline:

Frequency not reported: Serum sickness-like reaction[Ref]

Respiratory

Metronidazole:

Frequency not reported: Nasal congestion[Ref]

References

1. Product Information. Pylera (bismuth subcitrate potassium/metronidazo/TCN). Aptalis Pharma. 2022.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Some side effects may not be reported. You may report them to the FDA.